BARALDI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 9.069
NA - Nord America 5.655
AS - Asia 2.613
SA - Sud America 408
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 68
OC - Oceania 35
Totale 17.996
Nazione #
IT - Italia 6.589
US - Stati Uniti d'America 5.506
GB - Regno Unito 1.017
SG - Singapore 824
CN - Cina 568
VN - Vietnam 316
HK - Hong Kong 312
BR - Brasile 304
FR - Francia 273
SE - Svezia 194
DE - Germania 187
NL - Olanda 172
RU - Federazione Russa 127
BD - Bangladesh 98
IN - India 83
CH - Svizzera 74
KR - Corea 74
UA - Ucraina 70
CA - Canada 67
FI - Finlandia 66
TR - Turchia 64
ID - Indonesia 59
MX - Messico 53
ES - Italia 49
JP - Giappone 47
PL - Polonia 42
AR - Argentina 40
BG - Bulgaria 40
IE - Irlanda 36
AU - Australia 34
ZA - Sudafrica 21
IQ - Iraq 19
EC - Ecuador 18
AE - Emirati Arabi Uniti 17
EG - Egitto 17
IR - Iran 17
BE - Belgio 16
PK - Pakistan 16
TW - Taiwan 16
AT - Austria 15
PH - Filippine 15
CO - Colombia 13
MY - Malesia 11
NO - Norvegia 11
CR - Costa Rica 10
DK - Danimarca 10
CZ - Repubblica Ceca 9
HU - Ungheria 9
LT - Lituania 9
CL - Cile 8
GR - Grecia 8
AL - Albania 7
IL - Israele 7
JO - Giordania 7
PT - Portogallo 7
DZ - Algeria 6
NP - Nepal 6
PY - Paraguay 6
TN - Tunisia 6
UY - Uruguay 6
BY - Bielorussia 5
JM - Giamaica 5
KG - Kirghizistan 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
KE - Kenya 4
RS - Serbia 4
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
MD - Moldavia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
CU - Cuba 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
OM - Oman 2
SC - Seychelles 2
SI - Slovenia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
GY - Guiana 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 17.839
Città #
Southend 725
Ashburn 681
Milan 611
Singapore 513
Fairfield 507
Santa Clara 493
Rome 399
Chandler 315
Hong Kong 301
Woodbridge 252
Houston 215
Seattle 215
San Jose 211
Cambridge 178
Wilmington 164
Naples 148
Modena 144
Council Bluffs 126
Hefei 126
London 124
Beijing 121
Nyköping 119
Turin 118
Bologna 102
Ho Chi Minh City 102
Los Angeles 96
New York 96
Florence 93
Ann Arbor 86
Dearborn 82
Chicago 78
The Dalles 78
Hanoi 73
Seoul 59
Catania 58
Genoa 56
Palermo 55
Jacksonville 53
Bari 51
Helsinki 50
Lauterbourg 48
Jakarta 47
Verona 47
Parma 46
Moscow 42
San Diego 42
Pescara 39
Shanghai 36
Cagliari 35
Dallas 35
Princeton 32
São Paulo 32
Sofia 31
Salt Lake City 28
Zurich 28
Buffalo 27
Mexico City 25
Orem 25
Redwood City 25
Tokyo 25
Como 23
Munich 23
Warsaw 23
Amsterdam 21
Eugene 21
Atlanta 20
Brescia 20
Frankfurt am Main 20
L’Aquila 20
Dublin 19
Elk Grove Village 19
Fremont 19
Chennai 18
Messina 18
Paris 18
Phoenix 18
Toronto 18
Padova 17
Tampa 17
Ventimiglia 17
Bergamo 16
Dalmine 16
Monza 16
Perugia 16
Boston 15
Brasília 15
Bremen 15
Da Nang 15
Haiphong 15
Manchester 15
Philadelphia 15
Reggio Emilia 15
Düsseldorf 14
Lucca 14
Montreal 14
Trento 14
Dong Ket 13
Istanbul 13
Rio de Janeiro 13
Ancona 12
Totale 9.449
Nome #
Correlazione tra fumo di cannabis e pneumotorace spontaneo. 6.933
Allopregnanolone serum levels in female migraineurs 882
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 674
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 516
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 427
Monitoring of adherence to headache treatments by means of hair analysis 402
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 401
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 390
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 362
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 346
A case-control study of visually evoked postural responses in childhood with primary headaches 313
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 308
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 293
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 286
Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers. A case-control study. 272
Polypharmacy Among Headache Patients: A Cross-Sectional Study 267
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 258
Hair testing as a marker of adherence to headache treatments 255
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 255
Glutamate receptor antagonists with the potential for migraine treatment 253
Proteomic serum profile in menstrual-related and post menopause migraine 252
Erenumab per il trattamento preventivo dell'emicrania cronica: efficacia e sicurezza fino a un anno, predittori di risposta ed effetti della sospensione. 250
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache 246
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 245
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 243
Proteomic serum profile of female migraineurs 236
Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive age 231
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 206
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 189
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 189
Visually Evoked Postural Responses (VEPRs) in Children with Vestibular Migraine 185
Occlusal splint therapy in patients with Ménière’s disease and temporomandibular joint disorder 181
Topical Cannabidiol in the Treatment of digital ulcers in patients with Scleroderma: comparative Analysis and Literature Review 172
OnabotulinumtoxinA: Still the Present for Chronic Migraine 160
Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real-world clinical evidence in a severely impaired patient population 156
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 155
Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study 152
Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study 136
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 112
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study 106
Correction to: Monoclonal anti‑CGRP antibodies in post‑menopausal women: a real‑life study (Acta Neurologica Belgica, (2023), 123, 3, (1039-1047), 10.1007/s13760-023-02190-5) 101
Totale 17.996
Categoria #
all - tutte 49.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.244 0 64 114 138 48 79 64 116 127 117 220 157
2022/20232.537 166 191 187 224 189 230 188 229 305 139 252 237
2023/20242.547 212 213 227 207 265 193 238 221 160 185 225 201
2024/20253.140 178 151 145 267 432 385 259 206 333 195 279 310
2025/20264.174 332 170 260 540 751 247 506 196 362 369 228 213
2026/2027300 288 12 0 0 0 0 0 0 0 0 0 0
Totale 17.996